Sunfull Bio-tech Has Secured Spotlight at CPHI Shanghai 2025

Sunfull Bio-tech Has Secured Spotlight at CPHI Shanghai 2025

In 2024, China's pharmaceutical exports will show the characteristics of scale growth, structural optimization and diversified market development. Against the backdrop of high-quality development of the internationalization of the pharmaceutical industry, innovative drugs and biomedicine have become new driving force for export growth, and overseas models are becoming increasingly diversified. With the rise of emerging markets, my country's pharmaceutical product export potential will be further tapped, and pharmaceutical companies will also usher in greater market opportunities.

As the "business card" that leads China's pharmaceutical industry to the world, the World Pharmaceutical Raw Materials China Exhibition (CPHIChina) is linked to the World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition (PMECChina), and firmly holds a leading position in the industry with a global perspective, professional depth and differentiated advantages as the cornerstone. The two major exhibitions accurately focus on the growth hotspots of the pharmaceutical industry and keenly capture global market trends. They not only promote cross-regional collaborative development, but also strive to build a high-quality platform integrating trade, investment, exchange and cooperation.

Hunan Sunfull has successfully debuted at the CPHI Shanghai 2025 (June 24-26, Shanghai New International Expo Center, Halls E4-E5).

As a global leader in natural extracts, our ACTIVE MONOMERS，ANTHOCYANINS，BOTANICAL EXTRACTS，MUSHROOMS EXTRACTS and TEA INGREDIENTS are very competitive.

Next Stop: CPHI Korea 2025
We have finalized plans to showcase our broad product lines during CPHI Korea (August 2025, COEX Seoul). We sincerely invite you to visit the scene to celebrate this feast exclusively for pharmaceuticals!